Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

UAB School of Nursing offers health care services in rural communities

"If individuals, families, and communities don't have access, then they don't have the opportunity for a better life," asserts University of Alabama at Birmingham School of Nursing Dean Doreen C. Harper, PhD, RN, FAAN.

3 Apr 2013

BIND Therapeutics and Pfizer sign collaboration agreement to develop, commercialize Accurins

BIND Therapeutics, a clinical-stage biopharmaceutical company developing a new class of highly selective targeted and programmable therapeutics called Accurins, announced today that it has entered into a global collaboration agreement with Pfizer Inc. to develop and commercialize Accurins utilizing select small molecule targeted therapies.

3 Apr 2013

UAB School of Nursing raising bar on service for veterans

Partnering with Birmingham's VA Medical Center and with colleagues across a wide range of health care professions, the University of Alabama at Birmingham School of Nursing is raising the bar on service for veterans and their families.

3 Apr 2013

Researchers study how to reduce health risks in infants

Some partnerships were meant to be, and it would be difficult to imagine a more perfect one than June Cho, PhD, RN, and Wally A. Carlo, MD. An assistant professor of nursing in the University of Alabama at Birmingham School of Nursing, Cho sought out Carlo when she first came to UAB in 2008.

3 Apr 2013

Doctors give new hope for leukemia patients

Leukemia patients receive a bone marrow transplant, which allows them to build a "new" immune system. However, this immune system not only attacks cancer cells but healthy tissue too.

3 Apr 2013

Peace Corps volunteer plans to change others' lives

The two years Andrea Torre spent in Dimbwe Village in southern Zambia changed her life. Now she has come to the University of Alabama at Birmingham School of Nursing to learn the skills she needs to spend the rest of her career helping to change others' lives.

3 Apr 2013

Engineers develop prototype telerobotic platform for bladder cancer treatment

Although bladder cancer is the sixth most common form of cancer in the U.S. and the most expensive to treat, the basic method that doctors use to treat it hasn't changed much in more than 70 years.

3 Apr 2013

Penn neurosurgeons use diffusion tensor imaging to better adapt brain tumor surgeries

Neurosurgeons can visualize important pathways in the brain using an imaging technique called diffusion tensor imaging (DTI), to better adapt brain tumor surgeries and preserve language, visual and motor function while removing cancerous tissue.

2 Apr 2013

Men with Lynch syndrome face increased lifetime risk of prostate cancer

Men with an inherited genetic condition called Lynch syndrome face a higher lifetime risk of developing prostate cancer and appear to develop the disease at an earlier age, according to a new study led by researchers at the University of Michigan Comprehensive Cancer Center.

2 Apr 2013

New support program for single fathers

Men who have dependent children and whose spouses or partners died from cancer are an overlooked population. These fathers face unique challenges not addressed by traditional grief support groups that often attract an older, female population.

2 Apr 2013

NanoVelcro chip device can help identify cancerous cells for treating prostate cancer

A research team jointly led by scientists from Cedars-Sinai Medical Center and the University of California, Los Angeles, have enhanced a device they developed to identify and "grab" circulating tumor cells, or CTCs, that break away from cancers and enter the blood, often leading to the spread of cancer to other parts of the body.

2 Apr 2013

NewLink Genetics starts Phase 2 clinical study of indoximod in patients with metastatic breast cancer

NewLink Genetics Corporation, a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced the initiation of a double-blind, randomized, placebo-controlled Phase 2 clinical study of its first IDO (indoleamine-(2,3)-dioxygenase) pathway inhibitor, indoximod, in patients with metastatic breast cancer.

2 Apr 2013

UAB School of Nursing awarded HRSA grant to improve quality of care for underserved

The University of Alabama at Birmingham School of Nursing has received a three-year, $1.4-million grant from the U.S. Department of Health and Human Services Health Resources and Services Administration to develop and implement an innovative interprofessional collaborative health-care practice model that improves quality of care and outcomes for underserved patients with diabetes and other chronic conditions.

2 Apr 2013

Cancer Institute of New Jersey named recipient of 2013 ONS Employer Recognition Award

The Cancer Institute of New Jersey has been named as the recipient of the 2013 Oncology Nursing Society's Employer Recognition Award in the medium size employer category.

2 Apr 2013

Ensemble Therapeutics to highlight IL-17A inhibitor Ensemblin at 245th ACS National Meeting

Ensemble Therapeutics today announced that preclinical data showing the advantages of its Ensemblins, novel macrocyclic compounds against challenging drug targets, will be presented at the 245th American Chemical Society National Meeting being held April 7-11, 2013 in New Orleans, LA.

2 Apr 2013

Researchers discover new type of deadly intestinal lymphoma common in Asia

An international research team has identified a new type of deadly intestinal lymphoma that is particularly common in Asia. The team, led by clinician-scientists from the SingHealth Academic Healthcare Cluster, also developed a new diagnostic test to accurately identify these patients.

2 Apr 2013